AdvanSentinel Inc.
Company (SME/startup) / 中小企業・スタートアップ
Osaka, JapanAbout
AdvanSentinel is a joint venture of Shionogi and Shimadzu that develops advanced solutions for wastewater-based epidemiology (WBE) and environmental DNA (eDNA) monitoring. Its core technology, QuickConc™, enables highly sensitive nucleic acid concentration from diverse samples (wastewater, urine, CSF, etc.), supporting early detection of pathogens such as SARS-CoV-2, RSV, and tuberculosis, as well as biodiversity surveillance.
The company combines analytical instrumentation and pharmaceutical expertise to deliver:
-
High-sensitivity pathogen detection (≥30× enrichment, LoD ≤50 copies/mL)
-
Applications in infectious disease surveillance, biodiversity monitoring, and clinical diagnostics
-
Global collaborations with research institutes, NGOs, and diagnostic partners
Business Type / 業種
Disease Area / 疾患領域
Business Domain / 分野
Modalities / モダリティ
Additional questions
Researched company/organisation type / マッチングご希望企業・機関のタイプ
Researched disease area / マッチングご希望の疾患領域
Researched Modality / マッチングご希望のモダリティ
Researched Technologies / マッチングご希望の技術